 |
PDBsum entry 1w3y
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.4.2.2.1
- hyaluronate lyase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[hyaluronan](n) = n 3-(4-deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D- glucosamine + H2O
|
 |
 |
 |
 |
 |
[hyaluronan](n)
|
=
|
n
3-(4-deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D- glucosamine
Bound ligand (Het Group name = )
matches with 43.24% similarity
|
+
|
H2O
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
279:45990-45997
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes.
|
|
A.Botzki,
D.J.Rigden,
S.Braun,
M.Nukui,
S.Salmen,
J.Hoechstetter,
G.Bernhardt,
S.Dove,
M.J.Jedrzejas,
A.Buschauer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Hyaluronidases are enzymes that degrade hyaluronan, an important component of
the extracellular matrix. The mammalian hyaluronidases are considered to be
involved in many (patho)physiological processes like fertilization, tumor
growth, and metastasis. Bacterial hyaluronidases, also termed hyaluronate
lyases, contribute to the spreading of microorganisms in tissues. Such roles for
hyaluronidases suggest that inhibitors could be useful pharmacological tools.
Potent and selective inhibitors are not known to date, although L-ascorbic acid
has been reported to be a weak inhibitor of Streptococcus pneumoniae hyaluronate
lyase (SpnHL). The x-ray structure of SpnHL complexed with L-ascorbic acid has
been elucidated suggesting that additional hydrophobic interactions might
increase inhibitory activity. Here we show that L-ascorbic acid 6-hexadecanoate
(Vcpal) is a potent inhibitor of both streptococcal and bovine testicular
hyaluronidase (BTH). Vcpal showed strong inhibition of Streptococcus agalactiae
hyaluronate lyase with an IC(50) of 4 microM and weaker inhibition of SpnHL and
BTH with IC(50) values of 100 and 56 microM, respectively. To date, Vcpal has
proved to be one of the most potent inhibitors of hyaluronidase. We also
determined the x-ray structure of the SpnHL-Vcpal complex and confirmed the
hypothesis that additional hydrophobic interactions with Phe-343, His-399, and
Thr-400 in the active site led to increased inhibition. A homology structural
model of BTH was also generated to suggest binding modes of Vcpal to this
hyaluronidase. The long alkyl chain seemed to interact with an extended,
hydrophobic channel formed by mostly conserved amino acids Ala-84, Leu-91,
Tyr-93, Tyr-220, and Leu-344 in BTH.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Chemical structures of L-ascorbic acid and
L-ascorbic acid 6-hexadecanoate.
|
 |
Figure 3.
FIG. 3. A, the SpnHL binding site for L-ascorbic acid
6-hexadecanoate. Hydrogen bonds are represented as dotted lines.
Shown is the final sigmaA-weighted omit
map electron density calculated to a resolution of 1.65 Å
when the inhibitor was excluded from the model and contoured at
2.0 . B, schematic diagram
of interactions of L-ascorbic acid 6-hexadecanoate with SpnHL.
Hydrogen bonds are represented as dotted lines. Other residues
shown form hydrophobic interactions with the inhibitor. The
figure was made with LIGPLOT (35). C, binding mode of
hexasaccharide substrate. The coordinates of the hexasaccharide
substrate originate from its complex with SpnHL (Protein Data
Bank code 1loh [PDB]
(54)). D, binding mode of L-ascorbic acid 6-hexadecanoate. The
cryoprotectant xylitol molecule close to the inhibitor (see
text) is also shown (bottom right corner).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
45990-45997)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.A.Sloane,
C.Batt,
Y.Ma,
Z.M.Harris,
B.Trapp,
and
T.Vartanian
(2010).
Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2.
|
| |
Proc Natl Acad Sci U S A,
107,
11555-11560.
|
 |
|
|
|
|
 |
J.H.Baek,
T.H.Woo,
C.B.Kim,
J.H.Park,
H.Kim,
S.Lee,
and
S.H.Lee
(2009).
Differential gene expression profiles in the venom gland/sac of Orancistrocerus drewseni (Hymenoptera: Eumenidae).
|
| |
Arch Insect Biochem Physiol,
71,
205-222.
|
 |
|
|
|
|
 |
L.Zhang,
A.G.Bharadwaj,
A.Casper,
J.Barkley,
J.J.Barycki,
and
M.A.Simpson
(2009).
Hyaluronidase activity of human Hyal1 requires active site acidic and tyrosine residues.
|
| |
J Biol Chem,
284,
9433-9442.
|
 |
|
|
|
|
 |
P.Mishra,
R.Prem Kumar,
A.S.Ethayathulla,
N.Singh,
S.Sharma,
M.Perbandt,
C.Betzel,
P.Kaur,
A.Srinivasan,
V.Bhakuni,
and
T.P.Singh
(2009).
Polysaccharide binding sites in hyaluronate lyase--crystal structures of native phage-encoded hyaluronate lyase and its complexes with ascorbic acid and lactose.
|
| |
FEBS J,
276,
3392-3402.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Hirayama,
M.Yoshimura,
Y.Ozeki,
I.Sugawara,
T.Udagawa,
S.Mizuno,
N.Itano,
K.Kimata,
A.Tamaru,
H.Ogura,
K.Kobayashi,
and
S.Matsumoto
(2009).
Mycobacteria exploit host hyaluronan for efficient extracellular replication.
|
| |
PLoS Pathog,
5,
e1000643.
|
 |
|
|
|
|
 |
A.Senff-Ribeiro,
P.Henrique da Silva,
O.M.Chaim,
L.H.Gremski,
K.S.Paludo,
R.Bertoni da Silveira,
W.Gremski,
O.C.Mangili,
and
S.S.Veiga
(2008).
Biotechnological applications of brown spider (Loxosceles genus) venom toxins.
|
| |
Biotechnol Adv,
26,
210-218.
|
 |
|
|
|
|
 |
E.Bralley,
P.Greenspan,
J.L.Hargrove,
and
D.K.Hartle
(2008).
Inhibition of hyaluronidase activity by select sorghum brans.
|
| |
J Med Food,
11,
307-312.
|
 |
|
|
|
|
 |
M.A.Simpson,
and
V.B.Lokeshwar
(2008).
Hyaluronan and hyaluronidase in genitourinary tumors.
|
| |
Front Biosci,
13,
5664-5680.
|
 |
|
|
|
|
 |
V.B.Lokeshwar,
and
M.G.Selzer
(2008).
Hyalurondiase: both a tumor promoter and suppressor.
|
| |
Semin Cancer Biol,
18,
281-287.
|
 |
|
|
|
|
 |
J.K.Kutty,
E.Cho,
J.Soo Lee,
N.R.Vyavahare,
and
K.Webb
(2007).
The effect of hyaluronic acid incorporation on fibroblast spreading and proliferation within PEG-diacrylate based semi-interpenetrating networks.
|
| |
Biomaterials,
28,
4928-4938.
|
 |
|
|
|
|
 |
M.Nieuwdorp,
F.Holleman,
E.de Groot,
H.Vink,
J.Gort,
A.Kontush,
M.J.Chapman,
B.A.Hutten,
C.B.Brouwer,
J.B.Hoekstra,
J.J.Kastelein,
and
E.S.Stroes
(2007).
Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis.
|
| |
Diabetologia,
50,
1288-1293.
|
 |
|
|
|
|
 |
S.Olgen,
A.Kaessler,
D.Nebioğlu,
and
J.Jose
(2007).
New potent indole derivatives as hyaluronidase inhibitors.
|
| |
Chem Biol Drug Des,
70,
547-551.
|
 |
|
|
|
|
 |
G.Das,
and
S.Matile
(2006).
Substrate-independent transduction of chromophore-free organic and biomolecular transformations into color.
|
| |
Chemistry,
12,
2936-2944.
|
 |
|
|
|
|
 |
J.P.Gaut,
A.Belaaouaj,
J.Byun,
L.J.Roberts,
N.Maeda,
B.Frei,
and
J.W.Heinecke
(2006).
Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation.
|
| |
Free Radic Biol Med,
40,
1494-1501.
|
 |
|
|
|
|
 |
R.Stern,
and
M.J.Jedrzejas
(2006).
Hyaluronidases: their genomics, structures, and mechanisms of action.
|
| |
Chem Rev,
106,
818-839.
|
 |
|
|
|
|
 |
W.Hertel,
G.Peschel,
J.H.Ozegowski,
and
P.J.Müller
(2006).
Inhibitory effects of triterpenes and flavonoids on the enzymatic activity of hyaluronic acid-splitting enzymes.
|
| |
Arch Pharm (Weinheim),
339,
313-318.
|
 |
|
|
|
|
 |
M.J.Jedrzejas,
and
R.Stern
(2005).
Structures of vertebrate hyaluronidases and their unique enzymatic mechanism of hydrolysis.
|
| |
Proteins,
61,
227-238.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |